Related Experiment Video

Updated: Jun 7, 2026

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype
08:49

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype

Published on: March 18, 2020

Treatment of progressive multifocal leukoencephalopathy and idiopathic CD4+ lymphocytopenia

Amila Patel1, Julie Patel, Judy Ikwuagwu

  • 1The Methodist Hospital, Houston, TX 77030, USA. amila.patel@gmail.com

The Journal of Antimicrobial Chemotherapy
|October 22, 2010
PubMed

Insights

Progressive multifocal leukoencephalopathy (PML) and idiopathic CD4+ lymphocytopenia are rare, challenging diseases. This study discusses management strategies for patients with both conditions.

Area of Science:

  • Neurology
  • Immunology
  • Virology

Background:

  • Progressive multifocal leukoencephalopathy (PML) is a rare, demyelinating disease of the central nervous system caused by the JC polyomavirus.
  • JC virus infection typically occurs in immunocompromised individuals.
  • Idiopathic CD4+ lymphocytopenia is a rare condition characterized by a low count of CD4+ T-lymphocytes without a known cause.

Observation:

  • This issue presents a case report of a patient diagnosed with both PML and idiopathic CD4+ lymphocytopenia.
  • The co-occurrence of these two rare conditions presents significant management challenges.

Findings:

  • The paper details the diagnostic process and clinical course of the patient with co-existing PML and idiopathic CD4+ lymphocytopenia.
  • Available treatment strategies for this dual diagnosis are discussed, highlighting limited effective options.

Implications:

  • This case highlights the complexity of managing rare neurological and immunological disorders concurrently.
  • Understanding treatment options for PML in the context of idiopathic CD4+ lymphocytopenia is crucial for patient care.
  • Further research into effective therapies for these rare conditions is warranted.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...